These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 28000751

  • 1. Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction.
    Bugyei-Twum A, Abadeh A, Thai K, Zhang Y, Mitchell M, Kabir G, Connelly KA.
    Sci Rep; 2016 Dec 21; 6():39551. PubMed ID: 28000751
    [Abstract] [Full Text] [Related]

  • 2. The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction.
    Kobayashi M, Usui-Kawanishi F, Karasawa T, Kimura H, Watanabe S, Mise N, Kayama F, Kasahara T, Hasebe N, Takahashi M.
    PLoS One; 2017 Dec 21; 12(5):e0176676. PubMed ID: 28493895
    [Abstract] [Full Text] [Related]

  • 3. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q, Zhao Q, Zhang J, Sheng J.
    Mol Neurobiol; 2016 Jul 21; 53(5):3462-3476. PubMed ID: 26091790
    [Abstract] [Full Text] [Related]

  • 4. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Gan W, Ren J, Li T, Lv S, Li C, Liu Z, Yang M.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan 21; 1864(1):1-10. PubMed ID: 28986310
    [Abstract] [Full Text] [Related]

  • 5. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A, Menini S, Rossi C, Ricci C, Santini E, Blasetti Fantauzzi C, Iacobini C, Pugliese G.
    J Pathol; 2013 Nov 21; 231(3):342-53. PubMed ID: 23843215
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y, Yan X, Mi S, Li Z, Wang Y, Zhu H, Sun X, Zhao B, Zhao C, Zou Y, Hu K, Ding X, Sun A, Ge J.
    J Cell Mol Med; 2017 Jan 21; 21(1):4-12. PubMed ID: 27785882
    [Abstract] [Full Text] [Related]

  • 8. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats.
    Ma CH, Kang LL, Ren HM, Zhang DM, Kong LD.
    J Ethnopharmacol; 2015 Aug 22; 172():108-17. PubMed ID: 26117533
    [Abstract] [Full Text] [Related]

  • 9. The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease.
    Yu G, Bai Z, Chen Z, Chen H, Wang G, Wang G, Liu Z.
    Int Immunopharmacol; 2017 Feb 22; 43():203-209. PubMed ID: 28038382
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats.
    Zhu Q, Li XX, Wang W, Hu J, Li PL, Conley S, Li N.
    Am J Physiol Renal Physiol; 2016 Apr 01; 310(7):F621-F627. PubMed ID: 26764201
    [Abstract] [Full Text] [Related]

  • 11. Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy.
    Wen Y, Pan MM, Lv LL, Tang TT, Zhou LT, Wang B, Liu H, Wang FM, Ma KL, Tang RN, Liu BC.
    J Cell Biochem; 2019 Mar 01; 120(3):4291-4300. PubMed ID: 30260039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.
    Ding W, Guo H, Xu C, Wang B, Zhang M, Ding F.
    Oncotarget; 2016 Apr 05; 7(14):17479-91. PubMed ID: 27014913
    [Abstract] [Full Text] [Related]

  • 15. The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice.
    Sogawa Y, Nagasu H, Itano S, Kidokoro K, Taniguchi S, Takahashi M, Kadoya H, Satoh M, Sasaki T, Kashihara N.
    PLoS One; 2018 Apr 05; 13(10):e0203823. PubMed ID: 30281670
    [Abstract] [Full Text] [Related]

  • 16. Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway.
    Wang M, Yang L, Yang J, Wang C.
    BMC Complement Altern Med; 2019 May 22; 19(1):107. PubMed ID: 31118021
    [Abstract] [Full Text] [Related]

  • 17. NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury.
    Liu Z, Wang X, Wang Y, Zhao M.
    Immunol Res; 2017 Jun 22; 65(3):687-698. PubMed ID: 28215032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P2X7 receptor inhibition attenuated sympathetic nerve sprouting after myocardial infarction via the NLRP3/IL-1β pathway.
    Yin J, Wang Y, Hu H, Li X, Xue M, Cheng W, Wang Y, Li X, Yang N, Shi Y, Yan S.
    J Cell Mol Med; 2017 Nov 22; 21(11):2695-2710. PubMed ID: 28470940
    [Abstract] [Full Text] [Related]

  • 20. Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
    Wan Y, Xu L, Wang Y, Tuerdi N, Ye M, Qi R.
    Eur J Pharmacol; 2018 Aug 15; 833():545-554. PubMed ID: 29913124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.